Zacks Research Estimates Equifax’s Q3 Earnings (NYSE:EFX)

Equifax, Inc. (NYSE:EFX – Free Report) – Research analysts at Zacks Research issued their Q3 2028 earnings per share (EPS) estimates for Equifax in a report released on Tuesday, November 3rd. Zacks Research analyst Team forecasts that the credit services provider will post earnings per share of $2.81 for the quarter. The consensus estimate for Equifax’s current full-year earnings is $8.50 per share.

Equifax (NYSE:EFX – Get Free Report) last posted its quarterly earnings data on Tuesday, October 20th. The credit services provider reported $2.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $0.06. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.69 billion. Equifax had a return on equity of 22.48% and a net margin of 11.27%. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $2.04 earnings per share.

Several other research firms have also recently weighed in on EFX. Citigroup lowered their price target on Equifax from $238.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. BMO Capital Markets boosted their price objective on Equifax from $160.00 to $175.00 and gave the stock a “market perform” rating in a report on Wednesday, October 21st. Wells Fargo & Company decreased their price objective on shares of Equifax from $212.00 to $200.00 and set an “overweight” rating on the stock in a research report on Tuesday, September 22nd. Credit Suisse Group set a $160.00 price objective on shares of Equifax in a research report on Wednesday, September 30th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating on shares of Equifax in a research note on Tuesday, October 20th. Fourteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Equifax currently has a consensus rating of “Moderate Buy” and an average target price of $200.55.

Get Our Latest Research Report on Equifax

Equifax Price Performance

Equifax stock opened at $192.31 on Thursday. The stock has a market cap of $22.50 billion, a price-to-earnings ratio of 31.07, a PEG ratio of 1.92 and a beta of 1.27. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.12. The business has a 50-day simple moving average of $166.25 and a 200 day simple moving average of $177.01. Equifax has a 52 week low of $137.01 and a 52 week high of $228.67.

Hedge Funds Weigh In On Equifax

A number of large investors have recently modified their holdings of EFX. Raiffeisen Bank International AG boosted its stake in Equifax by 1.5% in the second quarter. Raiffeisen Bank International AG now owns 3,590 shares of the credit services provider’s stock worth $569,000 after buying an additional 53 shares in the last quarter. Axiom Investment Management LLC grew its position in Equifax by 8.9% during the third quarter. Axiom Investment Management LLC now owns 670 shares of the credit services provider’s stock valued at $92,000 after acquiring an additional 55 shares during the last quarter. V Square Quantitative Management LLC grew its position in Equifax by 3.8% during the first quarter. V Square Quantitative Management LLC now owns 1,730 shares of the credit services provider’s stock valued at $312,000 after acquiring an additional 64 shares during the last quarter. Aprio Wealth Management LLC raised its stake in shares of Equifax by 6.2% during the third quarter. Aprio Wealth Management LLC now owns 1,682 shares of the credit services provider’s stock worth $231,000 after acquiring an additional 98 shares in the last quarter. Finally, Droms Strauss Advisors Inc. MO ADV raised its stake in shares of Equifax by 1.9% during the first quarter. Droms Strauss Advisors Inc. MO ADV now owns 5,435 shares of the credit services provider’s stock worth $979,000 after acquiring an additional 100 shares in the last quarter. 96.20% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Equifax news, EVP John W. Gamble, Jr. sold 4,500 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $187.96, for a total transaction of $845,820.00. Following the sale, the executive vice president owned 69,055 shares in the company, valued at $12,979,577.80. This trade represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark Begor sold 37,792 shares of Equifax stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $182.80, for a total value of $6,908,377.60. Following the sale, the chief executive officer directly owned 289,922 shares of the company’s stock, valued at approximately $52,997,741.60. This trade represents a 11.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 46,292 shares of company stock worth $8,464,918. 1.70% of the stock is owned by insiders.

Equifax Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Monday, August 31st were paid a $0.56 dividend. This represents a $2.24 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend was Monday, August 31st. Equifax’s dividend payout ratio is currently 36.19%.

Key Stories Impacting Equifax

Here are the key news stories impacting Equifax this week:

  • Positive Sentiment: Zacks Research modestly raised its Q2 2028 EPS estimate to $2.81 from $2.79, offering a limited positive signal. Equifax analyst estimates
  • Neutral Sentiment: An Equifax survey found that rising costs are affecting how Canadians manage credit, with younger adults and families worried about financial milestones. It highlights consumer pressure but does not quantify an impact on Equifax’s results. Equifax survey on financial health
  • Negative Sentiment: Zacks Research cut several forecasts: FY2026 EPS to $8.49 from $8.63, FY2027 to $9.33 from $9.84, and FY2028 to $10.72 from $10.95. Estimates for multiple coming quarters were also reduced, including Q1 2027 to $1.98 from $2.12. The broad revisions suggest a softer earnings outlook, although the FY2026 estimate remains close to the $8.50 consensus cited in the reports. Equifax analyst estimates
  • Negative Sentiment: EVP John Gamble Jr. sold 4,000 shares for about $711,000. The sale was made under a pre-arranged trading plan, and he retained a substantial holding, which may temper the signal. Equifax insider sale

Equifax Company Profile

(Get Free Report)

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that provides information and services to help businesses, governments and consumers make informed financial and workforce decisions. The company is best known for its credit reporting activities, but its offerings also include identity verification, fraud prevention, income and employment verification, marketing services and risk management solutions.

Equifax provides consumer and commercial credit information, credit reports and related analytics to lenders and other businesses.

Recommended Stories

Earnings History and Estimates for Equifax (NYSE:EFX)

Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.